Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts ntaylor Tue, 01/03/2023 – 08:31 More: Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts Source: fierce
read moreCompany has reported booster details from a study of its inactivated COVID-19 candidate More: Valneva delivers additional data for COVID-19 booster vaccine Source: News
read moreSecond study will develop a bispecific antibody with potential applications in solid tumours More: Orion and Alligator reveal second stage of immuno-oncology research collaboration Source: News
read moreUnicycive’s pivotal trial of rival to Takeda kidney drug hits main goal, clearing path to FDA filing ntaylor Tue, 01/03/2023 – 03:20 More: Unicycive's pivotal trial of rival to Takeda kidney drug hits main goal, clearing path to FDA filing
read more© 1994 - 2026 B.M. Pharmaceuticals